T1	Condition 0 24	Congestive heart failure
T2	Condition 37 60	ventricular tachycardia
T3	Observation 26 36	history of
T4	Condition 62 86	ventricular fibrillation
T5	Condition 90 126	multifocal ventricular extrasystoles
T6	Condition 130 146	QTc prolongation
*	OR T5 T6 T4 T2 T1
R1	Has_temporal Arg1:T2 Arg2:T3	
T7	Condition 163 182	atrial fibrillation
T8	Procedure 194 215	anticoagulant therapy
T9	Observation 235 245	history of
T10	Condition 260 275	ischemic stroke
T11	Qualifier 246 259	cardioembolic
R2	Has_qualifier Arg1:T10 Arg2:T11	
T12	Condition 279 297	hemorrhagic stroke
*	OR T12 T10
T13	Scope 246 297	cardioembolic ischemic stroke or hemorrhagic stroke
R3	Has_temporal Arg1:T13 Arg2:T9	
T14	Scope 163 215	atrial fibrillation taking any anticoagulant therapy
*	OR T14 T13
T15	Observation 316 323	history
T16	Temporal 325 336	= 12 months
R4	Subsumes Arg1:T15 Arg2:T16	
T17	Condition 341 364	acute coronary syndrome
T18	Procedure 375 400	dual antiplatelet therapy
T19	Procedure 424 435	monotherapy
T20	Drug 441 448	aspirin
R5	AND Arg1:T19 Arg2:T20	
T21	Scope 341 400	acute coronary syndrome receiving dual antiplatelet therapy
*	OR T19 T21
T22	Scope 341 448	acute coronary syndrome receiving dual antiplatelet therapy, or patients receiving monotherapy with aspirin
R6	Has_temporal Arg1:T22 Arg2:T15	
T23	Condition 465 483	hepatic impairment
T24	Measurement 485 503	child-Pugh staging
T25	Value 505 520	calibration = 5
R7	Has_value Arg1:T24 Arg2:T25	
R8	Subsumes Arg1:T23 Arg2:T24	
T26	Condition 525 541	renal impairment
T27	Measurement 543 563	creatinine clearance
T28	Value 564 576	= 30ml / min
R9	Has_value Arg1:T27 Arg2:T28	
R10	Subsumes Arg1:T26 Arg2:T27	
T29	Temporal 579 585	recent
T30	Condition 586 598	peptic ulcer
R11	Has_temporal Arg1:T30 Arg2:T29	
T31	Observation 602 612	history of
T32	Condition 613 629	hypersensitivity
T33	Drug 633 643	cilostazol
T34	Condition 645 651	cancer
T35	Procedure 672 681	treatment
R12	AND Arg1:T34 Arg2:T35	
R13	AND Arg1:T32 Arg2:T33	
R14	Has_temporal Arg1:T32 Arg2:T31	
*	OR T23 T26 T32 T34 T30
